Fairmount Funds Management LLC - Director at Dianthus Therapeutics, Inc. /DE/

Issuer-level insider activity

Role
Director
Issuer ticker
DNTH on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Fairmount Funds Management LLC since 14 Aug 2025

Reported holdings for Fairmount Funds Management LLC in Dianthus Therapeutics, Inc. /DE/

Form 4 holding Director

Dianthus Therapeutics, Inc. /DE/

Security class
Common Stock
Shares / value
2,700,691
Estimated value
$32,408,292
Report date
27 Sep 2024
Price
$12.00
Ownership
By Fairmount Healthcare Fund II L.P.
Form 4 holding Director

Dianthus Therapeutics, Inc. /DE/

Security class
Pre-Funded Warrants (Right to Buy)
Shares / value
832,333
Estimated value
$9,987,164
Report date
22 Jan 2024
Price
$12.00
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Dianthus Therapeutics, Inc. /DE/

Security class
Stock Option (Right to Buy)
Shares / value
11,000
Estimated value
Report date
23 May 2024
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Transaction history for Fairmount Funds Management LLC in Dianthus Therapeutics, Inc. /DE/

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .